Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Angiographic changes in saphenous vein grafts are predictors of clinical outcomes.
Knatterud GL, White C, Geller NL, Campeau L, Forman SA, Domanski M, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Hunninghake DB, Terrin ML, Rosenberg Y. Knatterud GL, et al. Am Heart J. 2003 Feb;145(2):262-9. doi: 10.1067/mhj.2003.113. Am Heart J. 2003. PMID: 12595843 Clinical Trial.
Comparison of preoperative characteristics of men and women undergoing coronary artery bypass grafting (the Post Coronary Artery Bypass Graft [CABG] Biobehavioral Study).
Czajkowski SM, Terrin M, Lindquist R, Hoogwerf B, Dupuis G, Shumaker SA, Gray JR, Herd JA, Treat-Jacobson D, Zyzanski S, Knatterud GL. Czajkowski SM, et al. Among authors: knatterud gl. Am J Cardiol. 1997 Apr 15;79(8):1017-24. doi: 10.1016/s0002-9149(97)00040-4. Am J Cardiol. 1997. PMID: 9114757
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial Investigators.
Campeau L, Hunninghake DB, Knatterud GL, White CW, Domanski M, Forman SA, Forrester JS, Geller NL, Gobel FL, Herd JA, Hoogwerf BJ, Rosenberg Y. Campeau L, et al. Among authors: knatterud gl. Circulation. 1999 Jun 29;99(25):3241-7. doi: 10.1161/01.cir.99.25.3241. Circulation. 1999. PMID: 10385497
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators.
Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, Forrester JS, Gobel FL, Herd JA, Hickey A, Hoogwerf BJ, Terrin ML, White C. Knatterud GL, et al. Circulation. 2000 Jul 11;102(2):157-65. doi: 10.1161/01.cir.102.2.157. Circulation. 2000. PMID: 10889125 Clinical Trial.
Lessons from the post coronary artery bypass graft study in evaluating and controlling technical variability in angiographic trials. Post CABG Investigators.
White CW, Campeau L, Canner P, Domanski M, Forrester JS, Gobel FL, Herd JA, Hoogwerf BJ, Hunninghake DB, Knatterud GL, LoPresti F; Post CABG Investigators. White CW, et al. Among authors: knatterud gl. Am J Cardiol. 2001 Jan 1;87(1):40-3. doi: 10.1016/s0002-9149(00)01269-8. Am J Cardiol. 2001. PMID: 11137831
Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial.
Hoogwerf BJ, Waness A, Cressman M, Canner J, Campeau L, Domanski M, Geller N, Herd A, Hickey A, Hunninghake DB, Knatterud GL, White C. Hoogwerf BJ, et al. Among authors: knatterud gl. Diabetes. 1999 Jun;48(6):1289-94. doi: 10.2337/diabetes.48.6.1289. Diabetes. 1999. PMID: 10342818 Clinical Trial.
127 results